KRAS and pancreatic neoplasm: Dietary serine starvation is an experimental strategy to reduce the growth of some tumors [248]; unfortunately, KRAS-driven mouse models of pancreatic cancer are less responsive to depletion of serine, reflecting the ability of activated KRAS to increase the expression of enzymes involved in serine biosynthesis [248].